Propafenone

普罗帕酮

常用释义

n. 丙胺苯丙酮

扩展信息

普罗帕酮

国家基本药物目录医学百科 ... 美西律 Mexiletine 普罗帕酮 Propafenone 普鲁卡因胺 Procainamide ...

心律平

心律平(propafenone)为一有效抗心律失常药,临床应用已日趋广泛,国内外巳有关于其疗效的报道c1~3〕,但对其效应与血药浓度 …

普鲁帕酮

普鲁卡因碱的英语 procaine base in chinese... ... ) Prussian blue: 普鲁士兰 ) propafenone: 普鲁帕酮 ...

普洛帕酮

例如：氟卡尼（Flecainide）、普洛帕酮（Propafenone）等。　　（一）奎尼丁（Quinidine）

抗心律失常药心律平

【摘要】：正 I c 类抗心律失常药心律平(propafenone)在成人中已广泛应用,但在儿童中的应用经验有限。现为评价心律平对儿 …

盐酸普洛帕酮

盐酸普洛帕酮,Propafenone,在线英语词典,英文... ... ) Propafenone 盐酸普洛帕酮 ) chlorhydric acid 盐酸 ...

例句

Propafenone has no effects on QT interval, however it prolongs ventricular depolarization.

普罗帕酮对心室复极时间无影响，可延长心室除极时间。

Conclusion: The therapeutic effect of sotalol in the treatment of paroxysmal atrial fibrillation is better than propafenone.

结论：索他洛尔治疗阵发性心房颤动疗效优于普罗帕酮。

Conclusion Intravenous Propafenone treatment PSVT satisfactory results, and light toxicity, so it should be the p. . .

结论静脉注射心律平治疗 PSVT 效果满意，毒副作用轻，可作为治疗 PSVT 首选药物。

Results After treatment, propafenone group, the better Isoptin group, and the low rate of adverse reactions.

结果经过治疗后，心律平组的疗效优于异搏定组，且不良反应率低。

Objective: To improve the safety of propafenone in treatment of paroxysmal supraventricular tachycardia (PSVT) .

目的：评价国产艾司洛尔治疗阵发性室上性心动过速的疗效和安全性。

The adverse reaction rate associated with the heart was 8. 3% in propafenone group.

普罗帕酮组为 15.0%，与心脏有关的不良反应发生率为 8 .

Objective: It is to observe the effect of propafenone and amiodaron on chronic heart failure complicated with premature ventricular beats.

前言：目的：观察心律平、可达龙治疗慢性心衰合并室早的疗效。

The tachycardia could be terminated by propafenone, but could not by ATP and verapamil.

心动过速不能被腺苷三磷酸和维拉帕米终止，但可被普罗帕酮终止。

In the basis of comprehensive treatment, A group was given Capsule, B group was given propafenone.

在综合治疗的基础上，A 组服用心宁胶囊，B 组服用心律平。

ObjectiveTo compare the effect of amiodarone and propafenone on the cardioversion of paroxysmal auricular fibrillation (PAF).

目的对比研究胺碘酮与心律平转复阵发心房颤动的疗效。

Objective: It is to observe the effect of amiodarone and propafenone on atrial fibrillation.

前言：目的：探讨口服胺碘酮和心律平（普罗帕酮）治疗心房纤颤的效果。

A comparison between propafenone and digitalis in the therapeutic result of patients with chronic atrial fibrillation

普罗帕酮与洋地黄转复慢性心房颤动的比较

Study of tachypleus amebocyte lysate test for bacterial endotoxins in propafenone hydrochloride injection

盐酸普罗帕酮注射液细菌内毒素的鲎试验研究

Clinical observation between the effects of intravenous amiodarone and propafenone in the treatment of broad QRS tachycardia

胺碘酮治疗宽 QRS 型心动过速即时疗效的观察

Effect treated paroxysmal supraventricular tachycardia by propafenone intravenous therapy

静脉注射心律平治疗阵发性室上性心动过速疗效观察

Observation on propafenone hydrochloride to treat patients with paroxysmal supraventricular tachycardia

盐酸普罗帕酮治疗阵发性室上性心动过速的疗效观察

Sustained-Release Propafenone Reduces Frequency of Symptomatic Arrhythmia Recurrence in Patients With Atrial Fibrillation

普罗帕酮缓释剂可减少房颤心律失常的发作

Clinical research on intravenous ibutilide versus propafenone for immediate cardioversion of recent-onset atrial fibrillation

依布利特与普罗帕酮转复心房颤动的临床研究

更新时间：2025-04-30 05:12